Drug‐induced hyperthermia
Open Access
- 1 October 1993
- journal article
- Published by Wiley in Anaesthesia
- Vol. 48 (10) , 892-895
- https://doi.org/10.1111/j.1365-2044.1993.tb07423.x
Abstract
Drugs with antidopaminergic properties and those capable of stimulating serotonin release can be responsible for hyperthermia syndromes such as neuroleptic malignant syndrome and serotonin syndrome. Dopamine and serotonin are important neurotransmitters in temperature regulation and it is likely that these reactions result from drug-induced changes in neurotransmitter levels. We describe three cases of drug-induced hyperthermia, discuss their aetiology and management, with both general measures and therapies designed to redress neurotransmitter imbalance.Keywords
This publication has 31 references indexed in Scilit:
- The serotonin syndromeAnaesthesia, 1991
- Anesthetic management of a patient with neuroleptic malignant syndromeJournal of Clinical Anesthesia, 1990
- A rapidly progressing lethal case of neuroleptic malignant syndromeIntensive Care Medicine, 1990
- Pathogenesis and treatment of neuroleptic malignant syndromeGeneral Pharmacology: The Vascular System, 1990
- The association between the neuroleptic malignant syndrome and malignant hyperthermiaActa Anaesthesiologica Scandinavica, 1989
- Zuclopenthixol-Induced Neuroleptic Malignant Syndrome at Rechallenge and its Extrapyramidal EffectsThe British Journal of Psychiatry, 1989
- Repeated Anesthesia for a Patient With Neuroleptic Malignant SyndromeAnesthesiology, 1988
- Neuroleptic Malignant Syndrome Responsive to Carbidopa/LevodopaClinical Neuropharmacology, 1987
- Neuroleptic malignant syndrome: Successful treatment with dantrolene and bromocriptineAnnals of Neurology, 1983